Brief

The "Commission Implementing Regulation (EU) 2024/2563 of 24 September 2024 amending Implementing Regulation (EU) 2022/1646" has been PUBLISHED by the Register of Delegated and Implementing Acts on 27.9.2024. This regulation amends Implementing Regulation (EU) 2022/1646 to include additional content in national risk-based control plans and national randomised surveillance plans, and clarifies submission requirements for Member States. The changes aim to enhance transparency and consistency in official controls, particularly regarding pharmacologically active substances and residues.

This content is restricted.

Highlights content goes here...

This content is restricted.

Register of Delegated and Implementing Acts

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies